Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

PA

EU set to move to ensure medicines continue to flow between Britain and Northern Ireland

European Commission vice president Maros Sefcovic is expected to announce proposed new legislation tomorrow.

THE EUROPEAN UNION is set to announce proposals to ensure medicines can continue to flow unimpeded from Britain into Northern Ireland.

European Commission vice president Maros Sefcovic is expected to announce proposed new legislation tomorrow.

The UK’s Brexit Minister David Frost is understood to be aware of the development and is also expected to make a statement.

The issues surrounding medicines stem from the outworkings of the Northern Ireland Protocol, a part of the Brexit deal which means Northern Ireland remains covered by the EU’s pharmaceutical regulations.

As Northern Ireland receives most of its medicines from suppliers in Britain, there had been concerns that their movement could be impeded when a grace period ends in January.

However, the anticipated EU announcement would include a proposal to pass legislation that will enable the trade of medicines between Britain and Northern Ireland to continue.

A Brussels source said: “We believe the proposals solve all the issues that were raised about medicines.”

Any new legislation would be subject to ratification by both the European Council and the European Parliament.

Sefcovic and Frost are expected to speak by phone ahead of the announcement.

It is understood Frost has asked to meet with Northern Ireland’s political parties tomorrow, with party leaders anticipating a briefing on the development.

It is not expected that there will be a resolution to any other subjects, but there may be an indication from both sides on an approach to dealing with outstanding issues such as customs and food and plant and animal checks in the new year.

The proposed EU law change would allow British-based pharma suppliers to maintain their current regulatory arrangements.

It would mean companies in Britain could continue to act as a hub for the supply of generic medicines to Northern Ireland, without the need to establish bases in the region.

The proposals would also apply to other small markets which use British medicines, including the Irish Republic, Malta and Cyprus.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Author
Nora Creamer
View 3 comments
Close
3 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.

    Leave a commentcancel

     
    JournalTv
    News in 60 seconds